NEFAZODONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nefazodone, and when can generic versions of Nefazodone launch?
Nefazodone is a drug marketed by Ani Pharms, Aurobindo Pharma Usa, Chartwell Rx, Dr Reddys Labs Inc, Ivax Sub Teva Pharms, Roxane, Sun Pharm Inds Ltd, Teva, and Watson Labs. and is included in nine NDAs.
The generic ingredient in NEFAZODONE is nefazodone hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the nefazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nefazodone
A generic version of NEFAZODONE was approved as nefazodone hydrochloride by TEVA on September 16th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NEFAZODONE?
- What are the global sales for NEFAZODONE?
- What is Average Wholesale Price for NEFAZODONE?
Summary for NEFAZODONE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Drug Prices: | Drug price information for NEFAZODONE |
| DailyMed Link: | NEFAZODONE at DailyMed |
US Patents and Regulatory Information for NEFAZODONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076073-003 | Sep 16, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm Inds Ltd | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076409-003 | Sep 16, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roxane | NEFAZODONE HYDROCHLORIDE | nefazodone hydrochloride | TABLET;ORAL | 076196-004 | Sep 16, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
